Vycor Medical Inc
VYCO· OTC
Released Apr 14, 2023, during market hours
10-K filed Apr 14, 2023, 104 days after period end · 0001493152-23-012257
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | $271.26K | $273.72K | $291.62K | $307.45K |
| Net Income | -$116.55K | -$187.06K |
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
| -$200.36K |
| -$220.99K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.